These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 21107991)
1. Contribution of an adenine to guanine single nucleotide polymorphism of the matrix metalloproteinase-13 (MMP-13) -77 promoter region to the production of anticyclic citrullinated peptide antibodies in patients with HLA-DRB1*shared epitope-negative rheumatoid arthritis. Iwamoto N; Kawakami A; Arima K; Tamai M; Nakamura H; Kawashiri SY; Kita J; Okada A; Koga T; Kamachi M; Yamasaki S; Ichinose K; Ida H; Origuchi T; Eguchi K Mod Rheumatol; 2011 Jun; 21(3):240-3. PubMed ID: 21107991 [TBL] [Abstract][Full Text] [Related]
2. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis. Poór G; Nagy ZB; Schmidt Z; Brózik M; Merétey K; Gergely P Ann N Y Acad Sci; 2007 Sep; 1110():23-32. PubMed ID: 17911417 [TBL] [Abstract][Full Text] [Related]
3. Peptidyl arginine deiminase type IV (PADI4) haplotypes interact with shared epitope regardless of anti-cyclic citrullinated peptide antibody or erosive joint status in rheumatoid arthritis: a case control study. Bang SY; Han TU; Choi CB; Sung YK; Bae SC; Kang C Arthritis Res Ther; 2010; 12(3):R115. PubMed ID: 20537173 [TBL] [Abstract][Full Text] [Related]
4. Differential association of HLA-DRB1 alleles in Japanese patients with early rheumatoid arthritis in relationship to autoantibodies to cyclic citrullinated peptide. Furuya T; Hakoda M; Ichikawa N; Higami K; Nanke Y; Yago T; Kobashigawa T; Tokunaga K; Tsuchiya N; Kamatani N; Kotake S Clin Exp Rheumatol; 2007; 25(2):219-24. PubMed ID: 17543145 [TBL] [Abstract][Full Text] [Related]
5. The HLA-DRB1 shared epitope is associated with susceptibility to rheumatoid arthritis in African Americans through European genetic admixture. Hughes LB; Morrison D; Kelley JM; Padilla MA; Vaughan LK; Westfall AO; Dwivedi H; Mikuls TR; Holers VM; Parrish LA; Alarcón GS; Conn DL; Jonas BL; Callahan LF; Smith EA; Gilkeson GS; Howard G; Moreland LW; Patterson N; Reich D; Bridges SL Arthritis Rheum; 2008 Feb; 58(2):349-58. PubMed ID: 18240241 [TBL] [Abstract][Full Text] [Related]
6. HLA-DRB1 shared epitope-dependent DR-DQ haplotypes are associated with both anti-CCP-positive and -negative rheumatoid arthritis in Chinese Han. Liu X; Guo J; Jia Y; Zhao Y; Liu X; Cheng F; Li X; Zheng Y; Shi X; Li H; Huang C; Cheng Y; Lai B; Huang Y; Wang T; Ding B; Li Z PLoS One; 2013; 8(8):e71373. PubMed ID: 23951149 [TBL] [Abstract][Full Text] [Related]
7. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208 [TBL] [Abstract][Full Text] [Related]
8. Interaction of HLA-DRB1*09:01 and *04:05 with smoking suggests distinctive mechanisms of rheumatoid arthritis susceptibility beyond the shared epitope. Bang SY; Lee HS; Lee KW; Bae SC J Rheumatol; 2013 Jul; 40(7):1054-62. PubMed ID: 23637323 [TBL] [Abstract][Full Text] [Related]
9. A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies. Louzada-Júnior P; Freitas MV; Oliveira RD; Deghaide NH; Conde RA; Bertolo MB; Donadi EA Braz J Med Biol Res; 2008 Jun; 41(6):493-9. PubMed ID: 18560674 [TBL] [Abstract][Full Text] [Related]
10. The HLA-DRB1 shared epitope alleles differ in the interaction with smoking and predisposition to antibodies to cyclic citrullinated peptide. van der Helm-van Mil AH; Verpoort KN; le Cessie S; Huizinga TW; de Vries RR; Toes RE Arthritis Rheum; 2007 Feb; 56(2):425-32. PubMed ID: 17265477 [TBL] [Abstract][Full Text] [Related]
11. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status. Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396 [TBL] [Abstract][Full Text] [Related]
12. Brief Report: Main Contribution of DRB1*04:05 Among the Shared Epitope Alleles and Involvement of DRB1 Amino Acid Position 57 in Association With Joint Destruction in Anti-Citrullinated Protein Antibody-Positive Rheumatoid Arthritis. Terao C; Yano K; Ikari K; Furu M; Yamakawa N; Yoshida S; Hashimoto M; Ito H; Fujii T; Ohmura K; Yurugi K; Miura Y; Maekawa T; Taniguchi A; Momohara S; Yamanaka H; Mimori T; Matsuda F Arthritis Rheumatol; 2015 Jul; 67(7):1744-50. PubMed ID: 25777156 [TBL] [Abstract][Full Text] [Related]
13. Association of PTPN22 1858C→T polymorphism, HLA-DRB1 shared epitope and autoantibodies with rheumatoid arthritis. Raslan HM; Attia HR; Salama I; Ibrahim MH; Hassan EM; El Hussieny MS; El Menyawi MM; Amr KS Rheumatol Int; 2016 Aug; 36(8):1167-75. PubMed ID: 27324632 [TBL] [Abstract][Full Text] [Related]
14. Effect of the human leukocyte antigen HLA-DRB1 and anti-cyclic citrullinated peptide on the outcome of rheumatoid arthritis patients. Farouk HM; Mansour HE; Rahman SA; Mostafa AA; Shamy HA; Zarouk WA Braz J Med Biol Res; 2009 Sep; 42(9):831-8. PubMed ID: 19738989 [TBL] [Abstract][Full Text] [Related]
15. Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis. Lundström E; Källberg H; Smolnikova M; Ding B; Rönnelid J; Alfredsson L; Klareskog L; Padyukov L Arthritis Rheum; 2009 Apr; 60(4):924-30. PubMed ID: 19333936 [TBL] [Abstract][Full Text] [Related]
16. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Irigoyen P; Lee AT; Wener MH; Li W; Kern M; Batliwalla F; Lum RF; Massarotti E; Weisman M; Bombardier C; Remmers EF; Kastner DL; Seldin MF; Criswell LA; Gregersen PK Arthritis Rheum; 2005 Dec; 52(12):3813-8. PubMed ID: 16320316 [TBL] [Abstract][Full Text] [Related]
17. HLA-DRB1*0404 is strongly associated with high titers of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis. Charpin C; Balandraud N; Guis S; Roudier C; Toussirot E; Rak J; Lambert N; Martin M; Reviron D; Roudier J; Auger I Clin Exp Rheumatol; 2008; 26(4):627-31. PubMed ID: 18799094 [TBL] [Abstract][Full Text] [Related]
18. [Association between the synovial expression of cyclic citrullinated peptide and susceptibility variants of HLA-DRB1 shared epitope alleles and PADI 4 gene single nucleotide polymorphisms in patients with rheumatoid arthritis]. Li HB; Tie N; Jia YF; Shi L; Su Y; Zhang GZ; Wang Y; Bai LJ; Zhao J; Wang J; Xiao Z Zhonghua Yi Xue Za Zhi; 2012 Jun; 92(23):1607-11. PubMed ID: 22944128 [TBL] [Abstract][Full Text] [Related]
19. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for the development of rheumatoid arthritis in palindromic rheumatism. Tamai M; Kawakami A; Iwamoto N; Arima K; Aoyagi K; Eguchi K Scand J Rheumatol; 2010 Aug; 39(4):287-91. PubMed ID: 20476860 [TBL] [Abstract][Full Text] [Related]
20. The HLA-DRB1 shared epitope is not associated with antibodies against cyclic citrullinated peptide in Chinese patients with rheumatoid arthritis. Xue Y; Zhang J; Chen YM; Guan M; Zheng SG; Zou HJ Scand J Rheumatol; 2008; 37(3):183-7. PubMed ID: 18465452 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]